These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 30569091)
1. MicroRNA‑766 inhibits the malignant biological behaviours of pancreatic ductal adenocarcinoma by directly targeting ETS1. Li S; Yan G; Yue M; Kang Z; Wang L Mol Med Rep; 2019 Feb; 19(2):1380-1387. PubMed ID: 30569091 [TBL] [Abstract][Full Text] [Related]
2. Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma. Bhatti I; Lee A; James V; Hall RI; Lund JN; Tufarelli C; Lobo DN; Larvin M J Gastrointest Surg; 2011 Jan; 15(1):199-208. PubMed ID: 21088996 [TBL] [Abstract][Full Text] [Related]
3. ZFP36L2 promotes cancer cell aggressiveness and is regulated by antitumor microRNA-375 in pancreatic ductal adenocarcinoma. Yonemori K; Seki N; Kurahara H; Osako Y; Idichi T; Arai T; Koshizuka K; Kita Y; Maemura K; Natsugoe S Cancer Sci; 2017 Jan; 108(1):124-135. PubMed ID: 27862697 [TBL] [Abstract][Full Text] [Related]
4. A novel prognostic factor TIPE2 inhibits cell proliferation and promotes apoptosis in pancreatic ductal adenocarcinoma (PDAC). Sun Y; Cao S; Li Z; Liu X; Xu J; Tian Y; Shen S; Zhou Y Int J Med Sci; 2021; 18(9):2051-2062. PubMed ID: 33850476 [No Abstract] [Full Text] [Related]
5. High Expression of Long Noncoding RNA HOTAIRM1 is Associated with the Proliferation and Migration in Pancreatic Ductal Adenocarcinoma. Luo Y; He Y; Ye X; Song J; Wang Q; Li Y; Xie X Pathol Oncol Res; 2019 Oct; 25(4):1567-1577. PubMed ID: 30613920 [TBL] [Abstract][Full Text] [Related]
6. Up-regulation of CDHR5 expression promotes malignant phenotype of pancreatic ductal adenocarcinoma. Gao J; Wang M; Li T; Liu Q; You L; Liao Q J Cell Mol Med; 2020 Nov; 24(21):12726-12735. PubMed ID: 33025744 [TBL] [Abstract][Full Text] [Related]
7. Aberrant upregulation of KLK10 promotes metastasis via enhancement of EMT and FAK/SRC/ERK axis in PDAC. Cao XY; Zhang XX; Yang MW; Hu LP; Jiang SH; Tian GA; Zhu LL; Li Q; Sun YW; Zhang ZG Biochem Biophys Res Commun; 2018 May; 499(3):584-593. PubMed ID: 29621546 [TBL] [Abstract][Full Text] [Related]
8. LncRNA CCAT1 participates in pancreatic ductal adenocarcinoma progression by forming a positive feedback loop with c-Myc. Cheng C; Liu Z; Liu D; Chen H; Wang Y; Sun B Carcinogenesis; 2024 Feb; 45(1-2):69-82. PubMed ID: 37936306 [TBL] [Abstract][Full Text] [Related]
9. EREG silencing inhibits tumorigenesis via inactivating ERK/p38 MAPK pathway in pancreatic ductal adenocarcinoma. Liu F; Wu W; Cao W; Feng L; Yuan J; Ren Z; Dai N; Wang X; Li X; Yue S Biochim Biophys Acta Mol Basis Dis; 2024 Oct; 1870(7):167336. PubMed ID: 38972433 [TBL] [Abstract][Full Text] [Related]
10. Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties. Barrera LN; Evans A; Lane B; Brumskill S; Oldfield FE; Campbell F; Andrews T; Lu Z; Perez-Mancera PA; Liloglou T; Ashworth M; Jalali M; Dawson R; Nunes Q; Phillips PA; Timms JF; Halloran C; Greenhalf W; Neoptolemos JP; Costello E Cancer Res; 2020 Jul; 80(13):2861-2873. PubMed ID: 32393661 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-454 regulates stromal cell derived factor-1 in the control of the growth of pancreatic ductal adenocarcinoma. Fan Y; Xu LL; Shi CY; Wei W; Wang DS; Cai DF Sci Rep; 2016 Mar; 6():22793. PubMed ID: 26976451 [TBL] [Abstract][Full Text] [Related]
12. Peptidase inhibitor 16 promotes proliferation of pancreatic ductal adenocarcinoma cells through OASL signaling. Chen Q; Jiang LY; Cao C; Liu FY; Li DR; Wu PF; Jiang KR Mol Carcinog; 2024 May; 63(5):938-950. PubMed ID: 38353288 [TBL] [Abstract][Full Text] [Related]
13. EphA4 receptor, overexpressed in pancreatic ductal adenocarcinoma, promotes cancer cell growth. Iiizumi M; Hosokawa M; Takehara A; Chung S; Nakamura T; Katagiri T; Eguchi H; Ohigashi H; Ishikawa O; Nakamura Y; Nakagawa H Cancer Sci; 2006 Nov; 97(11):1211-6. PubMed ID: 16965393 [TBL] [Abstract][Full Text] [Related]
14. Identified γ-glutamyl cyclotransferase (GGCT) as a novel regulator in the progression and immunotherapy of pancreatic ductal adenocarcinoma through multi-omics analysis and experiments. Zheng Y; Xiong Q; Yang Y; Ma Y; Zhu Q J Cancer Res Clin Oncol; 2024 Jun; 150(6):318. PubMed ID: 38914714 [TBL] [Abstract][Full Text] [Related]
15. Regulator of calcineurin 1 gene isoform 4 in pancreatic ductal adenocarcinoma regulates the progression of tumor cells. Lao M; Zhang X; Ma T; Xu J; Yang H; Duan Y; Ying H; Zhang X; Guo C; Qiu J; Bai X; Liang T Oncogene; 2021 Apr; 40(17):3136-3151. PubMed ID: 33824473 [TBL] [Abstract][Full Text] [Related]
16. MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression. Frampton AE; Castellano L; Colombo T; Giovannetti E; Krell J; Jacob J; Pellegrino L; Roca-Alonso L; Funel N; Gall TM; De Giorgio A; Pinho FG; Fulci V; Britton DJ; Ahmad R; Habib NA; Coombes RC; Harding V; Knösel T; Stebbing J; Jiao LR Gastroenterology; 2014 Jan; 146(1):268-77.e18. PubMed ID: 24120476 [TBL] [Abstract][Full Text] [Related]
17. PAFAH1B3 is a KLF9 target gene that promotes proliferation and metastasis in pancreatic cancer. Dong C; Yao J; Wu Z; Hu J; Sun L; Wu Z; Yan J; Yin X Sci Rep; 2024 Apr; 14(1):9196. PubMed ID: 38649699 [TBL] [Abstract][Full Text] [Related]
18. The miRacle in Pancreatic Cancer by miRNAs: Tiny Angels or Devils in Disease Progression. Hawa Z; Haque I; Ghosh A; Banerjee S; Harris L; Banerjee SK Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27240340 [TBL] [Abstract][Full Text] [Related]
19. Bile accelerates carcinogenic processes in pancreatic ductal adenocarcinoma cells through the overexpression of MUC4. Gál E; Veréb Z; Kemény L; Rakk D; Szekeres A; Becskeházi E; Tiszlavicz L; Takács T; Czakó L; Hegyi P; Venglovecz V Sci Rep; 2020 Dec; 10(1):22088. PubMed ID: 33328627 [TBL] [Abstract][Full Text] [Related]
20. MUC1-C dictates neuroendocrine lineage specification in pancreatic ductal adenocarcinomas. Luan Z; Morimoto Y; Fushimi A; Yamashita N; Suo W; Bhattacharya A; Hagiwara M; Jin C; Kufe D Carcinogenesis; 2022 Feb; 43(1):67-76. PubMed ID: 34657147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]